Back to results
US 7,973,169 B2Granted
Modulators of ATP-Binding Cassette transporters
AssigneeVertex Pharmaceuticals Incorporated
InventorsSara S. Hadida Ruah, Mark T. Miller, Ashvani K. Singh, Thomas Cleveland, Lewis R. Makings, Matthew Hamilton, Peter D. J. Grootenhuis
Life of this patent
Estimating the term…
Abstract
The present invention relates to modulators of ATP-Binding Cassette (“ABC”) transporters or fragments thereof, including CF Transmembrane Regulator (“CFTR”), compositions thereof, and methods therewith. The present invention also relates to methods of treating ABC transporter mediated diseases using such modulators.
Claims15
A compound having formula (II) or formula (III):
- or a pharmaceutically acceptable salt thereof;
- wherein:
- X1 is a bond, O, S, CF2, CH2, or NR;
- R is H or R2
- A1 is aryl, or heteroaryl;
- each B1 is independently selected from a 3-7 membered monocyclic, saturated, unsaturated or aryl ring containing 0-4 heteroatoms selected from N, S, or O;
- wherein each A1 or B1 is optionally substituted with up to 4 substituents independently selected from R1, R2, R3, R4, or R5;
- each B1 is independently selected from 3-7 membered monocyclic, saturated, unsaturated or aromatic ring containing 0-4 heteroatoms selected from N, NH, S, or O;
- wherein each A1 is optionally substituted with up to 4 substituents independently selected from R1, R2, R3, R4, or R5;
- R1 is R6 or ((C1-C4)aliphatic)n-Y;
- n is 0 or 1;
- Y is halo, CN, CF3, OCF3, OH, NH2, NHR6, N(R6)2, COOH, COOR6 or OR6;
- or
- two R1 on adjacent ring atoms, taken together, form 1,2-methylenedioxy or 1,2-ethylenedioxy;
- R2 is aliphatic, wherein each R2 is optionally substituted with up to 2 substituents independently selected from R1, R4, or R5;
- R3 is a cycloaliphatic, aryl, heterocyclic, or heteroaryl ring optionally substituted with up to 3 substituents, independently selected from R1, R2, R4 or R5;
- R4 is OR5, C(O)R5, C(O)OR5, C(O)R6, C(O)OR6, C(O)N(R6)2, C(O)N(R5)2, or C(O)N(R5R6);
- R5 is a cycloaliphatic, aryl, heterocyclic, or heteroaryl ring, optionally substituted with up to 3 R1 substituents;
- and
- R6 is H or aliphatic;
- provided that for compounds of formula (II):
- (i) when both B1 are simultaneously phenyl and X1 is CH2, then A1 is not 4-fluoro-phenyl, 4-phenyl-piperidyl, phenyl, 2,4-dichloro-phenyl, 4-methoxy-phenyl, 3,4-dichloro-phenyl, 2,5-dichloro-phenyl, 4-nitro-phenyl, 4-bromo-phenyl, 4-methyl-phenyl, 2-chloro-phenyl, 1-naphthyl, 3-trifluoromethyl-phenyl, 2,3-dichlorophenyl, N-morpholinyl, 4-chloro-phenyl, 3-chloro-phenyl, or 3-nitro-phenyl;
- and
- (ii) when X1 is a bond, then A1 is not an optionally substituted 6-membered heteroaryl ring with 1-3 nitrogen ring atoms;
- and
- provided that for compounds of formula (III):
- (i) when X1 is a bond, one B1 is phenyl and the other B1 is N-piperidyl, then A1 is not:
- (ii) when X1 is a bond, then A1 is not an optionally substituted 6-membered heteroaryl ring with 1-3 nitrogen ring atoms.
25 more elements
Dependencies are inferred from the claim text.